Mycobacterium tuberculosis arabinomannan–protein conjugates protect against tuberculosis

This publication has 49 references indexed in Scilit:

• Identification of a Mycobacterium bovis BCG Auxotrophic Mutant That Protects Guinea Pigs against M. bovis and Hematogenous Spread of Mycobacterium tuberculosis without Sensitization to Tuberculin
  Infection and Immunity, 2000
• Nasal and parenteral immunizations with diphtheria toxoid using monoglyceride/fatty acid lipid suspensions as adjuvants
  Vaccine, 1999
• A new method of non-cross-linking conjugation of polysaccharides to proteins via thioether bonds for the preparation of saccharide?protein conjugate vaccines
  Vaccine, 1999
• CTL induction using synthetic peptides delivered in emulsions— critical role of the formulation procedure
  Vaccine, 1997
• Protective role of γ/δ T cells and α/β T cells in tuberculosis
  European Journal of Immunology, 1995
• CDlb restricts the response of human CD4−8−T lymphocytes to a microbial antigen
  Nature, 1992
• Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen
  Clinical and Experimental Immunology, 1992
• Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: The role of endogenous interleukin 1 in proliferative responses
  Cellular Immunology, 1989
• Oligosaccharide-protein conjugate: A novel approach for makingSalmonellaO-antigen immunogens
  FEMS Microbiology Letters, 1977
• CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS
  The Journal of Experimental Medicine, 1929